D. E. Shaw & Co »

Compass Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $277k 52k 5.37

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Palantir Technologies Cl A Call Option (PLTR)
Tesla Motors (TSLA)
Advanced Micro Devices Put Option (AMD)
Apple Put Option (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology Put Option (MU)
Booking Holdings (BKNG)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Texas Instruments Incorporated Call Option (TXN)

View all positions for D. E. Shaw & Co

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
BVF
Blackstone Group
State Street Corporation
Adage Capital Partners GP
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management
Blue Owl Capital Holdings

View all funds holding Compass Therapeutics